Dr. Adnan Sharif graduated from the University of Edinburgh in 2002 and underwent his medical and nephrology training in Cardiff and Birmingham respectively, while achieving his research MD in the field of post-transplantation diabetes. He took up his Consultant Nephrologist post at the Queen Elizabeth Hospital Birmingham in 2011 with a special interest in renal transplantation but clinical responsibility in all aspects of nephrology. He retains an active research focus and is currently Chief Investigator on a number of prospective cohort and randomized clinical trials (e.g. CAVIAR, FITNESS, AGEING and EpCOT). He has recently been appointed to the Board of Trustees for Kidney Research UK. In addition to his clinical and research interests, he is the secretary of the non-Government Organization Doctors Against Forced Organ Harvesting (DAFOH) which campaigns against illegal and unethical organ procurement around the globe and was nominated for the 2016 Nobel Peace Prize. He also sitson the steering committee for Give A Kidney, a registered charity that promotes non-directed altruistic kidney donation. Finally, he is a member of the National BAME Transplantation Alliance that seeks to promote blood, stem cell and organ donation from minority ethnic groups in the UK. Dr Graham Lipkin trained at Leeds General Infirmary, St Bartholomew's Hospital, London and University Hospital Birmingham. Dr Lipkin has specialised in renal medicine for over 30 years and was Clinical Director of Renal Medicine at University Hospital of Birmingham Foundation NHS Trust (UHBFT) for over 10 years. His clinical interests are in Renal (live donor) Transplantation, rare kidney disease and pregnancy in patients with CKD. He runs a research programme in Obstetric renal disease. He has led the development of the first adult Centre for Rare Diseases in the UK, sited in Birmingham which opened in 2016. He was elected President of the UK Kidney Association in June 2018 having been Clinical Vice President for 4 years. He was co-founder of the UK Renal Medicine quality improvement structure, the Kidney Quality Improvement Partnership and the joint Renal Association and British Renal Society Patient Safety Initiative. He is a Trustee of the UK Renal Registry and has sat on the Renal Clinical Reference Group and been an advisor to NICE. Dr Lipkin is a National Co-Lead for Renal GIRFT and authorised a national report for NHS England to guide the direction of renal services over the next 5-10 years.
